In a single center, 65% of cath lab activations for STEMI diagnosed with a prehospital ECG were cancelled when evaluated by an interventionalist.

New research suggests that cholesterol-lowering interventions could be useful even in people with a 10-year ASCVD risk below 7.5%.

The association was less robust among people taking antihypertensive drugs, suggesting a chance to mitigate the obesity epidemic’s effect on CV health.

The ESC Congress heads back to Munich with more “late-breaking” trials than could be crammed in a Hofbräuhaus beer stein. Stay hydrated.

The multicenter registry data show that even as LVEF remains unchanged, strain values deteriorate in concert with symptom development.

However, the decline appears to be related to other conditions, say researchers, with readmissions specific to stroke staying constant over time.

Physicians reacting to the controversial Netflix film say a balance of innovation and regulation is needed to ensure patient safety.

The FDA advises providers considering the SynCardia System’s TAH-t C2 Driver System to evaluate risk before deciding on treatment options.

Though not definitive, the study adds heft to the idea that it may be safe to selectively forgo aspirin after DES implantation.

In total, 8% of individuals have a threefold higher risk of CAD, which is on par with the elevated risk observed in those with the FH mutation.

Clinicians should recognize the various outcomes these patients may have depending on the stressor at play and tailor care accordingly, experts say.

Trainees must be able to balance viability, ischemia, and revascularization risks rather than succumbing to the occulostenotic reflex, one fellow argues.